Showing 5,061 - 5,080 results of 5,343 for search 'registration (developments OR development)', query time: 0.22s Refine Results
  1. 5061

    Predicting Disease Progression in Inoperable Localized NSCLC Patients Using ctDNA Machine Learning Model by Yuqi Wu, Canjun Li, Yin Yang, Tao Zhang, Jianyang Wang, Wanxiangfu Tang, Ningyou Li, Hua Bao, Xin Wang, Nan Bi

    Published 2024-10-01
    “…Conclusion In conclusion, we developed a cfDNA neomer profiling assay for predicting disease progression in inoperable NSCLC patients. …”
    Get full text
    Article
  2. 5062

    Smartphone-based Monitoring and cognition Modification Against Recurrence of Depression (SMARD): An RCT of Memory Bias Modification Training vs. Cognitive Control Training vs. Atte... by N. Ikani, A. Tyborowska, N. Kohn, N. Günther, G J. Siegle, A. H. Schene, J. A. S. Vorstman, C. J. Harmer, M. J. Kas, J. N. Vrijsen, H. G. Ruhé

    Published 2025-05-01
    “…Methods Here we describe the protocol for the Smartphone-based Monitoring and cognition Modification Against Recurrence of Depression (SMARD) study, aiming to investigate different forms of cognitive training programs administered via smartphones, in order to develop a second-generation recurrence prevention program. …”
    Get full text
    Article
  3. 5063

    Pharmacy Integrated Transitions (PIT) trial: a protocol for a pragmatic cluster-randomised crossover trial by Elizabeth Austin, Catherine Kim, Elizabeth J Austin, Giana H Davidson, Bryan A Comstock, Sarah E Monsell, Bryan Comstock, Mariam N Hantouli, Jocelyn Chaing, Arzu Ahmed Dervish, Nick J Gionet, Shalynn Howard, Nathalia Jimenez, Miriam Liberman, Edwin G Lindo, Zachary A Marcum, Thuan D Ong, Elina Serrano, Katherine Simons, Lydia S Sun, Oleg Zaslavsky

    Published 2024-12-01
    “…Current protocols often fail to ensure effective medication management and communication between hospital and SNF teams. Developed with input from multiple interest holders, the Pharmacy Integrated Transitions (PIT) programme enhances these transitions by improving medication safety and communication. …”
    Get full text
    Article
  4. 5064

    Leg Muscle Volume, Intramuscular Fat and Force Generation: Insights From a Computer‐Vision Model and Fat‐Water MRI by Andrew C. Smith, Javier Muñoz Laguna, Eddo O. Wesselink, Zachary E. Scott, Hazel Jenkins, Wesley A. Thornton, Marie Wasielewski, Jordan Connor, Scott Delp, Akshay S. Chaudhari, Todd B. Parrish, Sean Mackey, James M. Elliott, Kenneth A. Weber II

    Published 2025-02-01
    “…Decreases in lower limb muscle volume and increased intramuscular fat (IMF) are common findings in people with impaired mobility. We developed an automated method to extract markers of leg muscle health, muscle volume and IMF, from MRI. …”
    Get full text
    Article
  5. 5065
  6. 5066

    Effects of Physical Exercise on Executive Function in Schizophrenia: Systematic Review and Meta-Analysis by Nuria Pérez-Romero, Christian Campos-Jara, Caterina Pesce, Sergio Araya Sierralta, Enrique Cerda-Vega, Rodrigo Ramirez-Campillo, Rodrigo Campos-Jara, Cristian Martínez-Salazar, Cristián Arellano-Roco, Victoria Hernández-Cifuentes, Falonn Contreras-Osorio

    Published 2025-04-01
    “…Understanding the impact of physical exercise on these cognitive domains is essential for developing effective interventions. The aim of this review is to assess the effect of physical exercise on executive functions in adults diagnosed with schizophrenia spectrum disorders. …”
    Get full text
    Article
  7. 5067

    A personal sensing technology enabled service versus a digital psychoeducation control for primary care patients with depression and anxiety: a pilot randomized controlled trial by Colleen Stiles-Shields, Karen M. Reyes, Tanvi Lakhtakia, Shannon R. Smith, Olga E. Barnas, Elizabeth L. Gray, Charles J. Krause, Kaylee P. Kruzan, Mary J. Kwasny, Zara Mir, Sameer Panjwani, Steven K. Rothschild, Lisa Sánchez-Johnsen, Nathan W. Winquist, Emily G. Lattie, Nicholas B. Allen, Madhu Reddy, David C. Mohr

    Published 2024-11-01
    “…The current study: (1) developed a TES tailored for Primary Care patients with depression and/or anxiety, and (2) conducted a pilot randomized controlled trial to assess the efficacy of the TES compared to a digital psychoeducation control app. …”
    Get full text
    Article
  8. 5068
  9. 5069

    Cost-effectiveness analysis of proactive home visits compared with site-based community health worker care on antenatal care outcomes in Mali: a cluster-randomised trial by Osondu Ogbuoji, Caroline Whidden, Emily Treleaven, Youssouf Keita, Kassoum Kayentao, Ari Johnson, Jenny X Liu, Minahil Shahid, Mohamed Berthé, Armand Zimmerman, David Charles Boettiger, Coumba Traoré, Mahamadou Sogoba, Saibou Doumbia, Amadou Beydi Cissé

    Published 2024-12-01
    “…However, despite the success of CHW programmes in various countries, WHO has called for additional research to develop evidence-based models that optimise CHW service delivery and that can be replicated across geographies.Methods The ProCCM Trial was a cluster-randomised controlled trial to compare proactive home visits by CHWs (intervention, 69 village clusters) to the provision of CHW care at community fixed sites only (control, 68 village clusters) in the Bankass health district in Central Mali. …”
    Get full text
    Article
  10. 5070

    Human papillomavirus vaccine uptake and its determinants among women in Africa: an umbrella review by Berihun Agegn Mengistie, Amlaku Nigusie Yirsaw, Gebeyehu Lakew, Gebrehiwot Berie Mekonnen, Adamu Ambachew Shibabaw, Alex Ayenew Chereka, Gemeda Wakgari Kitil, Wubet Tazeb Wondie, Alemken Eyayu Abuhay, Eyob Getachew

    Published 2025-06-01
    “…Although HPV vaccination is the most effective form of primary prevention against cervical cancer, the accessibility and uptake of the HPV vaccine remain low in developing nations, particularly in Africa. Therefore, this umbrella review aimed to determine the pooled prevalence of human papillomavirus vaccine uptake and its determinant factors in Africa.MethodsThe protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO) under reference number CRD42024560032. …”
    Get full text
    Article
  11. 5071

    Maximising Embedded Pharmacists in AGed CAre Medication Advisory Committees (MEGA-MAC): protocol for implementing Australia’s new guiding principles for medication management in re... by Amanda J. Cross, Brooke Blakeley, Kate Laver, Terry P. Haines, Sarah N. Hilmer, Atish Manek, Alexandra Bennett, Angelita Martini, Lyntara Quirke, Mary Ann Kulh, Sara L. Whittaker, Dayna R. Cenin, Anthony Hobbs, Joanne Money, Karina Rieniets, Kris Salisbury, Alene Sze Jing Yong, J. Simon Bell

    Published 2025-08-01
    “…The intervention will involve knowledge broker dyads (pharmacist plus a MAC representative [e.g. nurse]) developing, implementing and evaluating RACF-specific local action plans to implement the Guiding Principles in up to 15 RACFs. …”
    Get full text
    Article
  12. 5072
  13. 5073
  14. 5074

    Automatic failure mode evaluation using non-linear phase contrast correction to improve flow measurement accuracy in cardiovascular magnetic resonance phase contrast imaging by Ana Beatriz Solana, Savine C.S. Minderhoud, Piotr A. Wielopolski, Juan Antonio Hernandez-Tamames, Ricardo P.J. Budde, Willem A. Helbing, Martin A. Janich, Alexander Hirsch

    Published 2025-01-01
    “…Here, we validate a recently developed non-linear phase contrast correction (nPCcor) algorithm that includes automatic failure mode classification in a large single-vendor multi-scanner retrospective study. …”
    Get full text
    Article
  15. 5075

    Co-designing and pilot-testing an infographic to support the consent process in an adaptive platform trial for adults in ICU with community-acquired pneumonia or COVID-19: a mixed... by Heather K. O’Grady, Kathy Smith, Sandra Dalziel, Barbara Dolanjski, Gyan Sandhu, Marlene Santos, Jackie Bosch, Lyn S. Turkstra, Srinivas Murthy, John C. Marshall, Michelle E. Kho, for the Canadian Critical Care Trials Group

    Published 2025-04-01
    “…Integration: Results from Phase 1 were used to develop a final consent infographic. Phase 2: Sixty-three patients were eligible for REMAP-CAP during the study period; 21 were eligible (33%) for the SWAT. …”
    Get full text
    Article
  16. 5076

    Artificial intelligence-based personalised rituximab treatment protocol in membranous nephropathy (iRITUX): protocol for a multicentre randomised control trial by Céline Fernandez, Marion Cremoni, Laurent Bailly, Kevin Zorzi, Vesna Brglez, Barbara Seitz-Polski, Maxime Teisseyre, Alexandre Destere, Sylvain Benito

    Published 2025-04-01
    “…Underdosing of rituximab is associated with treatment failure. We have previously developed a machine learning algorithm to predict the risk of underdosing. …”
    Get full text
    Article
  17. 5077

    Understanding the potential factors affecting carers’ mental health during end-of-life home care: a meta synthesis of the research literature by Gunn Grande, Tracey Shield, Kerin Bayliss, Christine Rowland, Jackie Flynn, Penny Bee, Alexander Hodkinson, Maria Panagioti, Morag Farquhar, Danielle Harris, and Alison Wearden

    Published 2022-12-01
    “…Understanding what factors may affect carers’ mental health is important in developing strategies to maintain mental health, through identifying carers at risk who may need added monitoring and support or developing interventions to change modifiable factors. …”
    Get full text
    Article
  18. 5078

    Evaluating a mobile-based short virtual course on family planning for frontline health workers in India by Farhad Ali, Gelsey Bennett, S. Vijay Paulraj, Sanjay Kumar Paswan, Vir Narayan, Adam Wills

    Published 2021-06-01
    “…The method for this descriptive study is divided into two broad categories: (i) course development, promotion, and rollout processes, and (ii) course evaluation. …”
    Get full text
    Article
  19. 5079

    Nab-paclitaxel plus cisplatin versus gemcitabine plus cisplatin as first-line treatment in advanced biliary tract cancer: results of a multicentre, randomised, phase II trial by Xiao Yang, Yu-Hong Dai, Hui Peng, Ming-Sheng Zhang, Qiang Fu, Shun-Fang Liu, Li Sun, Yan-Mei Zou, Hai-Sheng Xu, Ping Qiu, Hong Qiu, Qiao Huang, Heng-hui Cheng, Liang Zhuang

    Published 2025-08-01
    “…Methods Patients with unresectable advanced-stage tumors, or those who have developed recurrence or metastasis following initial radical surgery, between January 2021 and November 2022 were included. …”
    Get full text
    Article
  20. 5080